Oral glucocorticoid-sparing effects of mepolizumab. A real-life study.

A. Bjerrum (Aarhus, Denmark), J. Schmid (Aarhus, Denmark), T. Skjold (Aarhus, Denmark)

Source: International Congress 2018 – Innovative therapies in asthma and COPD
Session: Innovative therapies in asthma and COPD
Session type: Poster Discussion
Number: 601
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Bjerrum (Aarhus, Denmark), J. Schmid (Aarhus, Denmark), T. Skjold (Aarhus, Denmark). Oral glucocorticoid-sparing effects of mepolizumab. A real-life study.. 601

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: